• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Layoffs and / or reorganization

Quote




















anonymous said:
In respiratory this time last year they reorged so doubtful in this division.
Click to expand...

Are you high? Seriously, respi has zero pipeline line and it is at the end of its life cycle. The competitors in our area have white spaced large areas that we still call on. At best, this sales force should have 1 Bi rep calling on pulms and high targets and contract the rest. So maybe 1-2 reps per state at max! In fact, all contract reps would probably not change the numbers too much! I think you are lucky that BI has a sentimental devotion to respi because I think you are way over staffed.
 












anonymous said:
We have heard that it will be one manager per state (district) and no more crossing over state lines to manage. When is this happening?
Click to expand...

No more reps crossing state lines to cover neighboring territories either. If you don’t live in the same state as your territory, you are gone. Find a position where you live. Geography will be a deal breaker
 




anonymous said:
No more reps crossing state lines to cover neighboring territories either. If you don’t live in the same state as your territory, you are gone. Find a position where you live. Geography will be a deal breaker
Click to expand...

Reps home location and geography of territory have always been the main factors. Work load & where you live like always.
 




anonymous said:
Are you high? Seriously, respi has zero pipeline line and it is at the end of its life cycle. The competitors in our area have white spaced large areas that we still call on. At best, this sales force should have 1 Bi rep calling on pulms and high targets and contract the rest. So maybe 1-2 reps per state at max! In fact, all contract reps would probably not change the numbers too much! I think you are lucky that BI has a sentimental devotion to respi because I think you are way over staffed.
Click to expand...
Hmmmm I'm the only rep and I put 3800 miles a month on my car. White space? My competition has 3 reps in my footprint to little ol me..Over staffed..HARDLY.
 








AOB insider here - HH generic approval imminent before year end. This + Trelegy SNDA for Asthma this year = reorganization. Get ready respiratory folks...it’s going to be a very bumpy ride into 2021. Good idea to update that resume and look for opportunities elsewhere...
 




anonymous said:
AOB insider here - HH generic approval imminent before year end. This + Trelegy SNDA for Asthma this year = reorganization. Get ready respiratory folks...it’s going to be a very bumpy ride into 2021. Good idea to update that resume and look for opportunities elsewhere...
Click to expand...
Opportunities are plentiful right now. Recruiters are looking at LinkedIn and calling people. Don't let BI decide your fate.
 




anonymous said:
AOB insider here - HH generic approval imminent before year end. This + Trelegy SNDA for Asthma this year = reorganization. Get ready respiratory folks...it’s going to be a very bumpy ride into 2021. Good idea to update that resume and look for opportunities elsewhere...
Click to expand...


AOB insider TY for this "drop" pray tell who is orchestrating the generic HH for approval later this year? Do you have a link? Name?
 
















“We are going to be transparent, honest and forthcoming......” lol

Maybe they just need more time to release the email. This only happened on February 10, 2020. Haha
 








Top Bottom
Back
Quote